-
PurposeExpresses the amyloid-beta protein (42 aa), containing an exogenous methionine (Abeta(M1-42)), when expressed in BL21* DE3 p LysS E. coli cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 71875 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET vector
-
Backbone manufacturerunknown
- Backbone size w/o insert (bp) 4700
-
Modifications to backboneVector is a modified pET vector. Restriction digest sites for Abeta gene are Nde1 (5') and Sac1 (3')
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameAbeta(M1-42)
-
Alt nameamyloid-beta 42
-
Alt nameabeta 42
-
SpeciesH. sapiens (human)
-
Insert Size (bp)129
-
Entrez GeneAPP (a.k.a. AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4)
- Promoter T7
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Nde1 (not destroyed)
- 3′ cloning site Sac1 (not destroyed)
- 5′ sequencing primer 5'- ATG GAC GCT GAA TTC CGT CAC GAC TCT GGT TAC GAA GTT CAC CAC CAG AAG CTG GTG -3'
- 3′ sequencing primer 5'- GTG GGT TCT AAC AAG GGT GCT ATC ATC GGT CTG ATG GTT GGT GGC GTT GTG -3' (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pET-Sac-Abeta(M1-42) was a gift from Dominic Walsh (Addgene plasmid # 71875 ; http://n2t.net/addgene:71875 ; RRID:Addgene_71875) -
For your References section:
A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. Walsh DM, Thulin E, Minogue AM, Gustavsson N, Pang E, Teplow DB, Linse S. FEBS J. 2009 Mar;276(5):1266-81. doi: 10.1111/j.1742-4658.2008.06862.x. 10.1111/j.1742-4658.2008.06862.x PubMed 19175671